Identifying ARHGEF12 As an Important Regulator of Erythropoiesis by Calculating Red Blood Cell Transfusion for Chemotherapy Induced Anemia and by Conditional Knockout Mouse Model
Yangyang Xie,Ruichi Wu,Li Gao,Xiaoxiao Chen,Xiao-Jian Sun,Shuhong Shen
DOI: https://doi.org/10.1182/blood-2018-99-117724
IF: 20.3
2018-01-01
Blood
Abstract:Various degree of anemia post chemotherapy was frequently observed among patients even with the same treatment protocol and similar intensity. In this study, we performed whole exon sequencing in 31 individuals having multiple RBC transfusions (MRTs) and 31 patients with no RBC transfusion (NRT), all from the SCMC-ALL 2005 cohort. For children with different age and mass, the RBC transfusion amount was normalized by body surface area, and only post-remission transfusions were calculated to minimize the effect of the disease itself. Patients who received more than 8 RBC units/m2 were defined as MRT. By a genome-wide association study (GWAS), 1708 single nucleotide polymorphisms (SNPs) of 281 genes passed the criterion of the primary sort: a call rate of >95% and P<0.01. Of interest, most of the SNPs were located in introns adjacent to exons, suggesting that these polymorphisms are relevant to chemotherapy-induced anemia by regulating gene expression. Thus, these genes should be highly expressed in erythroid. Sorted according to the Differentiation Map Portal (DMAP) database, 10 genes were at the top of the list TFDP2, CHPT1, LPIN2, TNS1, BSG, ANXA7, EPB42, RAP1GAP, ARHGEF12, and ABCC4 which expressed in erythroid 2 fold above the average. Indeed, some of these genes have well-known associations with RBC function, such as with cytotoxicity susceptibility to chemotherapy agents and with erythropoiesis. Of note, 3 of them are related to small GTPases, including ARHGEF12, a RhoA specific guanine exchange factor.